Steven Quay – Atossa Therapeutics

Atossa Therapeutics leading clinical trial that may improve pulmonary function in COVID-19 patients.  Dr. Steven Quay, physician scientist and Atossa Therapeutics CEO, joins ‘America’s Newsroom’ to explain.

Let’s Talk About How We Can Help You

This field is for validation purposes and should be left unchanged.